Related Experiment Video
Updated: Jul 5, 2026

Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter
Published on: April 17, 2026
G-quadruplex homeostasis is a determinant of PARP inhibitor toxicity in BRCA2-deficient cells
Abhishek Bharadwaj Sharma1,2, Joanna Krwawicz1, Leandre Tappenden1
1Department of Biochemistry, University of Oxford, South Parks Road, Oxford, UK.
Abstract:
Inhibition of PARPs is a key strategy to treat tumours with defects in homologous recombination (HR), including those with mutations in the tumour suppressor gene BRCA2. PARP inhibitors generate replication stress, creating a dependence on HR to repair the resulting DNA damage. However, the DNA lesions generated upon PARP inhibition that impede replication fork progression and trigger a requirement for BRCA2 in cell survival are poorly defined. Here, we demonstrate that elevated levels of G-quadruplex (G4) DNA structures is a determinant of genome instability and PARP inhibitor toxicity, while suppressing these structures results in PARP inhibitor resistance. The HUWE1-associated stress response protein HAPSTR1 and BRCA2 function in parallel pathways to PARP1/PARP2 to suppress G4 levels during S-phase. Mechanistically, PARP1/PARP2 disruption in HAPSTR1 or BRCA2-deficient cells leads to G4-replication conflicts, ssDNA gaps, replication-associated DNA damage and genome instability. HAPSTR1 turnover is regulated through HUWE1-dependent proteasome degradation. As such, HUWE1 disruption results in elevated HAPSTR1 and suppression of elevated G4 levels in BRCA2-deficient cells, resulting in PARP inhibitor resistance. Together, these data identify G4 structures as a determinant of PARP inhibitor toxicity, while the HAPSTR1/HUWE1 axis is essential to suppress these structures and confer PARP inhibitor resistance.
Insights
G-quadruplex DNA structures drive PARP inhibitor toxicity in BRCA2-deficient tumors. Suppressing these structures via the HAPSTR1/HUWE1 pathway confers resistance, offering new therapeutic strategies.
Area of Science:
- Cancer Biology
- DNA Repair Mechanisms
- Genomic Instability
Background:
- PARP inhibitors are crucial for treating homologous recombination (HR)-deficient tumors, like those with BRCA2 mutations.
- PARP inhibition induces replication stress, necessitating HR for DNA repair.
- The specific DNA lesions driving PARP inhibitor toxicity and BRCA2 dependence remain unclear.
Purpose of the Study:
- To investigate the role of G-quadruplex (G4) DNA structures in PARP inhibitor response.
- To identify mechanisms that suppress G4 levels and influence PARP inhibitor sensitivity.
Main Methods:
- Cellular assays to assess G4 DNA levels, replication stress, and DNA damage.
- Investigated the roles of HAPSTR1, BRCA2, HUWE1, and PARP1/PARP2 in G4 suppression.
- Utilized proteasome degradation assays to study HAPSTR1 turnover.
Main Results:
- Elevated G4 DNA levels correlate with PARP inhibitor toxicity and genome instability.
- HAPSTR1 and BRCA2 act in parallel pathways to suppress G4 structures during S-phase.
- Disruption of HAPSTR1 or BRCA2 leads to G4-replication conflicts and DNA damage.
- HUWE1-mediated degradation of HAPSTR1 suppresses G4 levels, conferring PARP inhibitor resistance in BRCA2-deficient cells.
Conclusions:
- G4 DNA structures are key determinants of PARP inhibitor toxicity.
- The HAPSTR1/HUWE1 axis is essential for suppressing G4 structures and conferring PARP inhibitor resistance.
- Targeting G4 structures or the HAPSTR1/HUWE1 pathway may overcome PARP inhibitor resistance.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Long-patch Base Excision Repair
Abnormal Proliferation
Restarting Stalled Replication Forks
Negative Regulator Molecules

